Inventor
Karen G. Bulock
Inventor
Mendon, MA, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes35%
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C12YEnzymes6%
PatentTitleYear
11,021,707Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA202111,001,845Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)202110,913,948RNA interference in dermal and fibrotic indications202110,138,485Neutral nanotransporters20189,963,702RNA interference in dermal and fibrotic indications20189,340,786'RNA interference in dermal and fibrotic indications'2016Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2016–2018Patents assigned to RXI PHARMACEUTICALS CORP (3)· patent assignee history
2016–2018Patents assigned to BULOCK KAREN G (2)· patent assignee history
2016–2018Patents assigned to KAMENS Joanne (2)· patent assignee history
2016–2018Patents assigned to KHVOROVA ANASTASIA (2)· patent assignee history
2016–2021Based in Mendon, MA, US· patent location history
2021Patents assigned to PHIO PHARM CORP (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PHIO PHARM CORP | 3 | 2021 |
| RXI PHARMACEUTICALS CORP | 3 | 2016–2018 |
| BULOCK KAREN Gself | 2 | 2016–2018 |
| KAMENS Joanne | 2 | 2016–2018 |
| KHVOROVA ANASTASIA | 2 | 2016–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Mendon, Massachusetts, US | 6 | 2016–2021 |